Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Matthew T. Downs
Observed names:
M Downs,
M. Downs,
Matthew Downs
Institution:
Statistics Collaborative
Observed institutions:
San Francisco General Hospital,
University of California, Los Angeles,
Massachusetts General Hospital,
Statistics Collaborative,
University of Virginia,
University of Pennsylvania
show all 6
OpenAlex ID:
A5111696776
Enzyme-Replacement Therapy in Life-Threatening Hypophosphatasia
2012
·
Michael P. Whyte
, Cheryl R. Greenberg
, et al.
·
New England Journal of Medicine
·
598
PDF
Prolonged survival and tissue trafficking following adoptive transfer of CD4ζ gene-modified autologous CD4+ and CD8+ T cells in human immunodeficiency virus–infected subjects
2000
·
Ronald T. Mitsuyasu
, Peter A. Anton
, et al.
·
Blood
·
470
Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study
2018
·
Miriam Nickel
, Alessandro Simonati
, et al.
·
The Lancet Child & Adolescent Health
·
161
WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled Study
2009
·
Afif Ben Salah
, Pierre A. Buffet
, et al.
·
PLoS neglected tropical diseases
·
107
PDF
Reports to Independent Data Monitoring Committees: An Appeal for Clarity, Completeness, and Comprehensibility
2018
·
Kevin A. Buhr
, Matthew Downs
, et al.
·
Therapeutic Innovation & Regulatory Science
·
25
Revisiting Co-trimoxazole Prophylaxis for African Adults in the Era of Antiretroviral Therapy: A Randomized Controlled Clinical Trial
2021
·
Matthew B Laurens
, Randy G Mungwira
, et al.
·
Clinical Infectious Diseases
·
17
Outcome Measures to Assess Efficacy of Treatments for Age-Related Macular Degeneration
2009
·
Janet Wittes
, Matthew Downs
·
Ophthalmology
·
7
2-Year Outcomes Of Phase Iib, Randomized, Double-Blind Trial Of GC4419 Versus Placebo To Reduce Severe Oral Mucositis Due To Concurrent Radiotherapy And Cisplatin For Head And Neck Cancer
2020
·
C.M. Anderson
, C.M. Lee
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
2
PDF
Reply to Ramirez and Diaz-Quijano
2021
·
Matthew B Laurens
, Matthew Downs
, et al.
·
Clinical Infectious Diseases
·
1
Tumor Outcomes of Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer
2020
·
C.M. Anderson
, C.M. Lee
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
1
O62 – 1673 The natural history of late infantile CLN2 disease: striking homogeneity of clinical progression in two independently obtained large clinical cohorts
2013
·
A Schulz
, M Nickel
, et al.
·
European Journal of Paediatric Neurology
Show more works
View as search
Works count:
11
Citation count:
1,389
H-index:
7
I10-index:
6
Year
Topic
Type